Intellectual Property and Technology Commercialization

Transforming Our Discoveries Into Therapeutics

The Intellectual Property & Technology Commercialization program embodies the spirit of the National Jewish Health brand promise, Science Transforming Life®. We accelerate the development of basic scientific research towards clinical application by identifying and protecting the Center's intellectual property and facilitating business partnerships for technology development, licensing, and commercialization.

National Jewish Health currently has in its portfolio:

• 110 active technologies developed from our research
• 81 active US patents protecting these technologies
• 50 percent of those active US patents are licensed to biotechnology companies for the development of therapeutics consistent with the spirit of the National Jewish Health brand promise, Science Transforming Life®.

Additionally, in the 10 years since the Intellectual Property & Technology Commercialization program was created, National Jewish Health has:

• executed 170 license agreements, of which 96 are still active;
• executed a total of 1317 material transfer agreements; and
• helped create 8 start-up companies.

Technologies from National Jewish Health

To browse a list of the technologies ready for licensing or further development, select one of the following:

• Biotechnologies: By Type and Application or by Title
• Research Tools: Antibodies, Cell Lines,  Animal Models & Transgenic Mice
• Biomedical Devices
• Start Up Companies created with National Jewish Health technologies

Featured Technology: Method To Prevent Biofilm Formation on Contact Lenses and in Wounds

Staff

Contact Information
National Jewish Health
Intellectual Property and Technology Commercialization
1400 Jackson St., M206
Denver, CO 80206
Fax: 303-270-2352